Demirtaş Erciyes-Mid urethral fibrin fixation technique (DE-MUFFT) for female stress urinary incontinence: A case series

Abstract

Factors including suburethral blood flow impairment, collagen deficiency, and the lack of tissue healing factors are known to play a role in stress urinary incontinence (SUI). Autologous fibrin (AF) appears to be a viable material for the treatment of SUI. The aim of this study was to present the initial clinical outcomes of a novel technique named “XXX-Mid Urethral Fibrin Fixation Technique (DE-MUFFT)” that involved the placement of AF material in the suburethral space instead of sling material (mesh). In this study, the clinical outcomes of five women with pure SUI who underwent the placement of AF material in the suburethral space were examined retrospectively. The complaint of urine leakage during physical exertion and patients’ quality of life were assessed using Incontinence Quality of Life Scale (I-QoL), International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF), Incontinence Impact Questıonnaire (IIQ-7), and 24-h pad test. Patient outcomes were evaluated preoperatively, at sixth week and third month postoperatively. Significant improvement was obtained in the quality of life tests and 24-h pad test. In all patients, the complaint of urine leakage disappeared almost completely. No adverse event or postoperative complication occurred in any of the patients. These results indicated that DE-MUFFT can be a promising procedure in the treatment of SUI due to its biocompatibility, minimally invasive nature, re-applicability, and cost-effectivity.

Keywords

• Stress urinary incontinence
• sling
• autologous fibrin

References

1. Boukerrou, M., Boulanger, L., Rubod, C., Lambaudie, E., Dubois, P., Cosson, M., 2007. Study of the biomechanical properties of synthetic mesh implanted in vivo. Eur J Obstet Gynecol Reprod Biol. 134: 262-7.
2. Brazzelli, M., Javanbakht, M., Imamura, M., Hudson, J., Moloney, E., Becker, F., Wallace, S., Omar, M. I., Shimonovich, M., MacLennan, G., Ternent, L., Vale, L., Montgomery, I., Mackie, P., Saraswat, L., Monga, A., Craig, D., 2019.Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation. Health Technol Assess. 24: 1-306.
3. Carter, P., Fou, L., Whiter, F., Delgado Nunes, V., Hasler, E., Austin, C., Macbeth, F., Ward, K., Kearney, R., 2020. Management of mesh complications following surgery for stress urinary incontinence or pelvic organ prolapse: a systematic review. BJOG. 127: 28-35.
4. Chen, C.C., Hijaz, A., Drazba, J.A., Damaser, M.S., Daneshgari, F., 2009. Collagen remodeling and suburethral inflammation might account for preserved anti-incontinence effects of cut polypropylene sling in rat model. Urology. 73: 415-20.
5. Dobberfuhl, A.D., De, E.J., 2015. Female stress urinary incontinence and the mid-urethral sling: is obstruction necessary to achieve dryness? World J Urol. 33: 1243-50. Greiman, A., Kielb, S., 2012. Revisions of mid urethral slings can be accomplished in the office. J Urol. 188: 190-3.
6. Irwin, D.E., Kopp, Z.S., Agatep, B., Milsom, I., Abrams, P., 2011. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 108: 1132–8.
7. Karimi, K., Rockwell, H., 2019. The Benefits of Platelet-Rich Fibrin. Facial Plast Surg Clin North Am. 27: 331-40.
8. Klinge, U., Binneboesel, M., Kuschel, S., Schuessler, B., 2007. Demands and properties of alloplastic implants for the treatment of stress urinary incontinence. Expert Rev Med Devices. 4: 349-59.

9. Matz, E.L., Pearlman, A.M., Terlecki, R.P., 2018. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 59: 61-65.
10. Miron, R.J., Zhang, Y., 2018. Autologous liquid platelet rich fibrin: A novel drug delivery system. Acta Biomater. 75: 35-51.
11. Miron, R.J., Chai, J., Zheng, S., Feng, M., Sculean, A., Zhang, Y., 2019. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation. J Biomed Mater Res A. 107: 2257-71.
12. Nikolopoulos, K.I., Pergialiotis, V., Perrea, D., Doumouchtsis, S.K., 2016. Restoration of the pubourethral ligament with platelet rich plasma for the treatment of stress urinary incontinence. Med Hypotheses. 90: 29-31.
13. Okui, N., 2019. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol. 37: 885-9.
14. Park, K.K., Kim, S.D., Huh, J.S., Kim, Y.J., 2017. A study of clinical predictors associated with intrinsic sphincter deficiency in women with stress urinary incontinence. Int Neurourol J. 21: 139–42.
15. Ross, S., Robert, M., Lier, D., Eliasziw, M., Jacobs, P., 2011. Surgical management of stress urinary incontinence in women: safety, effectiveness and cost-utility of trans-obturator tape (TOT) versus tension-free vaginal tape (TVT) five years after a randomized surgical trial. BMC Womens Health. 11: 34.
16. Say, F., Buyukceran, I., Coskun, S., 2021. Two different regenerative injections in patients diagnosed with secondary hip osteoarthritis: A report of two cases. J Exp Clin Med. 38: 204-7.
17. Shirvan, M.K., Alamdari, D.H., Ghoreifi, A., 2013. A novel method for iatrogenic vesicovaginal fistula treatment: autologous platelet rich plasma injection and platelet rich fibrin glue interposition. J Urol. 189: 2125-9.
18. Zambon, J.P., Williams, K.J., Bennington, J., Badlani, G.H., 2019. Applicability of regenerative medicine and tissue engineering for the treatment of stress urinary incontinence in female patients. Neurourol Urodyn. 38: 76-83.